Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Total delay and associated factors among tuberculosis patients in Jimma Zone, Southwest Ethiopia

  • Berhane Megerssa Ereso ,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Visualization, Writing – original draft, Writing – review & editing

    berhanemegerssa2004@gmail.com

    Affiliations Department of Community Medicine and Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway, Department of Health Policy and Management, Faculty of Public Health, Institute of Health, Jimma University, Jimma, Ethiopia

  • Mette Sagbakken,

    Roles Conceptualization, Methodology, Supervision, Visualization, Writing – review & editing

    Affiliation Department of Nursing and Health Promotion, Faculty of Health Sciences, Oslo Met- Oslo Metropolitan University, Oslo, Norway

  • Christoph Gradmann,

    Roles Methodology, Supervision, Writing – review & editing

    Affiliation Department of Community Medicine and Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway

  • Solomon Abebe Yimer

    Roles Conceptualization, Formal analysis, Methodology, Supervision, Visualization, Writing – review & editing

    Affiliations Department of Microbiology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway, Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway

Abstract

Background

Delays in diagnosis and treatment of tuberculosis (TB) increases severity of illness and continued transmission of TB in the community. Understanding the magnitude and factors associated with total delay is imperative to expedite case detection and treatment of TB. The aim of this study was to determine the length and analyze factors associated with total delay.

Methods

Analytic cross-sectional study was conducted in Jimma Zone, Southwest Ethiopia. All newly diagnosed TB patients > 15 years of age were included from randomly selected eight districts and one town in the study area. A structured questionnaire was applied to collect socio-demographic and clinical data. The median total delay was used to dichotomize the sample into delayed and non-delayed patient categories. Logistic regression analysis was used to analyse the association between independent and outcome variables. A p-value < 0.05 were considered statistically significant.

Results

A total of 1,161 patients were included in this study. The median total delay was 35 days. Patients who had swelling or wound in the neck region were more likely to be delayed than their counterpart [adjusted odds ratio (AOR) = 3.02, 95% confidence interval (CI): 1.62, 5.62]. Women were more likely to experience longer total delay (AOR = 1.46, 95% CI:1.00, 2.14) compared to men. Patients who had poor knowledge of TB were more likely to be delayed compared to those who had good knowledge (AOR = 3.92, 95% CI: 2.65, 5.80).

Conclusion

The present study showed long total delay in diagnosis and treatment of TB. Targeted interventions that enhance TB knowledge and practice, expedite early suspect identification, referral and management of all forms of TB is imperative to reduce total delay in diagnosis and treatment of TB.

1. Introduction

Tuberculosis (TB) is a major cause of illness in low-resource countries. It is among the top 10 causes of death, and has been the leading cause of death from a single infectious agent in recent years [1, 2]. There were an estimated 10.0 million TB cases, and 1.5 million deaths due to TB in 2020 [3]. The 30 high TB burden countries are responsible for the majority (86%) of the estimated incident TB cases [2].

Ethiopia is among the high TB burden countries [3]. TB is a major public health problem and one of the leading infectious diseases in Ethiopia. There were an estimated 140 new incident TB cases per 100,000 population in 2020 and TB mortality rate of 19 per 100,000 populations in 2019 in Ethiopia [4]. Ethiopia accounts for 90,000 (3%) of annually missed TB cases worldwide [2, 5]. A recent national case detection rate of all forms of TB was 76 percent, which is below the target of World Health Organization [3, 6]. One of the contributing factors for low case detection is the delay in diagnosis and treatment of TB. Delay in diagnosis and treatment is commonly divided into three components (patients’ delay, health system’s delay and total delay). While patient delay refers to the delay period from onset of the major TB symptoms to first visit to a medical provider, health system delay encompasses the delay period from first visit to a medical provider to first start of anti-TB treatment. Total delay is defined as the delay period from start of major TB symptoms to first start of anti-TB treatment. Delay in TB diagnosis and treatment remains a major problem of TB control program generally in low and middle income countries [7] particularly in Ethiopia [8, 9]. Patients’ health care seeking delay differs among different regions of Ethiopia [10, 11].

Prompt diagnosis and treatment is crucial for efficient TB control program performance and achieving the End TB targets. The target set for the End TB Strategy for the year 2035 include: 1) reduction of TB mortality by 95%, 2) decreasing TB incidence by 90% (i.e compared to the baseline of 2015), and 3) to certify that no family is suffered with TB related catastrophic costs [12]. The End TB Strategy targets can only be realized if diagnosis, treatment, and preventive services for TB are delivered based on the context of universal health coverage, which implies that all people with TB should be early detected and properly treated [2, 5]. Delayed diagnosis and treatment of TB cases has major role in the transmission of the disease in the community in most high TB burden countries. Early diagnosis and proper treatment of TB will reduce severity of illness, prevent transmission, increase cure rate, and prevent the development of drug-resistant TB [2, 13].

Various studies have been conducted on delays in diagnosis and treatment of TB in different parts of the world [1421]. A systematic review and meta-analysis conducted in low- and middle-income countries showed that the median total delay ranged from 30 in Zimbabwe and Vietnam to 366.5 days in Afghanistan [7]. Another systematic review and meta-analysis conducted in Ethiopia revealed that the median diagnostic of 45days. The prevalence of diagnostic delay in Ethiopia ranged from 9.57% in Addis Ababa city and 68.84% in Somali region [22]. Various factors that are associated with diagnostic and treatment delay were identified in earlier studies in Ethiopia and elsewhere. Some of these factors included poor knowledge about TB [23], patient first visit to lower level facilities [21], long distance to health facility [19], low level of income [23], being female [19, 24], being illiterate [15, 22], perceived TB stigma [25], rural residence [19, 22], having extra-pulmonary TB [14, 22, 26], having smear negative pulmonary TB [26], self-treatment [21, 23, 26], being HIV negative [22, 23], absence of chest pain and presence of haemoptysis [17] etc.

Although various studies were conducted in Ethiopia and elsewhere to assess TB diagnostic and treatment delay, there is limited study to date that has been conducted to assess the length and associated factors of total delay in diagnosis and treatment of TB in Jimma Zone, Ethiopia. The length of total delay and associated factors may vary according to the local setting, including the socio-demographic and economic condition of the population in the study area [10, 11]. Understanding the contribution of these factors is important to propose targeted interventions to address diagnostic and treatment delay at the local setting. Therefore, the aim of the present study was to determine the length and analyze factors associated with total delay in Jimma Zone, Ethiopia.

2. Materials and methods

2.1. Study setting and design

Analytic cross-sectional study was conducted among all forms of TB patients who started treatment from September 2016 to October 2017. The study was conducted in Jimma Zone, Oromia Region, Southwest Ethiopia. Jimma Zone is located 354 kilometres from Addis Ababa, the capital city of Ethiopia, with a total area of 199,316.18 square kilometres [Jimma Zone health office, 2016]. According to 2017 projected population census, Jimma Zone had an estimated population of 3,261,371, of which 49.9% were women [27]. In 2016, the Zone had 17 districts and two town administrations. A total of seven public hospitals (five were primary, one general and one specialized); 120 health centres, and 494 health posts were registered in the study area during the study period. The hospitals and health centres have been providing TB diagnostic and treatment services. Health extension workers at health posts have been rendering TB treatment services, screening and referring of TB suspects to the nearest health facilities for confirmatory testing. Non-governmental health facilities such as the Catholic mission and several private clinics were also providing TB diagnostic and treatment services. In 2016, a total of 3,008 all forms of TB patients were identified in Jimma Zone. Among these, 1,468 patients were bacteriologically confirmed pulmonary TB cases [Jimma Zone health office, 2016; Jimma town health office, 2016].

2.2. Study population and sampling

A total of 1,161 newly diagnosed TB patients were included from sampled districts’ public health facilities and health posts. Patients whose age was less than 15 years, who could not respond to the interview questions and critically ill patients were excluded from the study. Eight districts and one town administration were selected from the 17 districts and two town administrations by using a simple random sampling method. Subsequently, all TB DOTS sites in the sampled districts and a town administration were covered by the study.

This study is part of a PhD project. It follows a recently published sub-study that compared community- versus facility-based DOTS in a cohort study that enrolled a total of 1,161 study participants [28]. We included all of the 1,161 study participants in the current study. However, in order to address the research objective in the current study, a total sample of 422 calculated using formula for estimating single proportion could have been enough (i.e. considering 50% proportion of delay of more than one month at 95% confidence interval and a margin error of 5%). The inclusion of the 1,161 study participants in the current study is advantageous as it provides more than adequate representative population to address the research questions. The sample size was proportionally allocated to the selected public health facilities based on the previous one year’s (before the study’s start) patient flow. The study participants were consecutively included until the required sample size was achieved [Fig 1].

thumbnail
Fig 1. Schematic presentation of sampling procedure for TB patients, Jimma Zone, 2017.

https://doi.org/10.1371/journal.pone.0281546.g001

2.3. Data collection and analysis

A structured questionnaire was developed based on the national and WHO’s guidelines; and previous studies [2934]. The questionnaire was translated to the local language (Afan Oromo) by a professional whose mother tongue is the local language. It was checked and peer reviewed for any inconsistencies between the translated version and the original English version of the questions. The translated version of the questionnaire was re-translated to English by another professional who fluently spoke and wrote the local language. Then, it was pre-tested to check for the clarity and applicability of the questionnaire for the context of the study area. Based on the findings of the pre-test, modifications such as clarifying statements were made. We recruited experienced data collectors and supervisors and they were provided with the required training on the data collection and supervision techniques. The whole process of data collection was supervised by the principal investigator. The study participants were consecutively enrolled starting from September 2016 to October 2017. They were all interviewed during the enrolment time. Clinical data such as HIV status, main mode of TB diagnosis, TB classification were collected by a checklist attached to the questionnaire from TB register.

The collected data were checked for completeness and consistency, coded and entered into the EpiData entry client software, version 4.4.3.1. Then, the data were exported to the statistical package for social sciences software (SPSS) version 21 for analysis. Descriptive statistics were computed for the variables. To assess TB knowledge, a score of one was given for the correct responses and a score of zero was given for wrong responses. Then the total knowledge score and median score were computed. Those with a total score of less than the median value were categorized as having poor knowledge, while those who scored greater than or equal to the median value were classified as having good TB knowledge. Likewise, the total perceived stigma and median scores were determined. Those with a total score of less than the median value were classified as not having perceived stigma, whereas those who scored greater than or equal to the median value were categorized as having perceived stigma.

The median total delay was used to categorize the sample into delayed and non-delayed patient groups. To analyse the association of independent variables with the dependent variable, we used binary logistic regression analysis. First, bivariable analysis was performed for each independent variable against the respective outcome variable and crude odds ratio (COR) was calculated. Multivariable analysis was conducted comprising candidate variables in the bivariable analysis that scored a p-value of < 0.25 with a backward stepwise method. Besides, the respective adjusted odds ratios (AOR) and 95% confidence intervals (CI) were computed. A p-value < 0.05 was considered statistically significant.

2.4. Operational definitions

Patient delay: the time from onset of symptoms (cough) until first visit to a medical provider.

Health system delay: the time between the first visit to a medical provider and the first start of anti-TB treatment.

Total delay: the period between onset of TB symptoms and the first start of anti-TB treatment (the sum of patient delay and health system delay).

Delayed: operationally defined as delayed if the period between the onset of TB symptoms and first start of anti-TB treatment is more than the calculated median total delay (> 35 days).

Community based DOTS: TB treatment offered at a health post or patient’s residence by a HEW or a trained TB treatment supporter.

Facility based DOTS: TB treatment offered at public health facility (health center or hospital) by a trained health care provider.

Medical provider/ formal health care provider: include hospitals, health centres, health posts, private clinics, and drug retail outlets.

Non formal-health care providers: traditional healers or herbalists, religious healers.

2.4.1. TB diagnosis.

The national guideline for TB, and DR-TB was followed to diagnosis and treat TB [5]. Health care providers identify, triage and examine individuals who present with persistent cough of two or more weeks (any duration for HIV positive), fever for more than two weeks, night sweats, and weight loss of more than 1.5 kg per month. TB diagnosis is made with proper investigations using one or more of the following methods: mycobacteriologcal examination, chest x-ray, and cytological/histopathology (analysis of body parts/fluids) examinations. Acid-fast-bacilli (AFB) smear microscopy is the most common method used for TB diagnosis and follow up of treatment response. A patient is diagnosed as a pulmonary positive TB case, when he/she has at least one positive result on AFB microscopy, or when his/ her Xpert MTB/RIF test result is positive for mycobacteria. A patient is diagnosed as a pulmonary negative TB case when he/she has signs and symptoms suggestive of TB with at least two negative result on AFB smear microscopy, and secondly, when his/her Xpert MTB/RIF test results detects mycobacterium and a decision to treat with a full course of anti-TB drugs is made. The decision is made based on suggestive findings from supporting laboratory tests and with the aid of proper clinical examination [5].

2.5. Ethical considerations

Ethical clearance was sought from the Regional Committee for Medical Research Ethics (REK Øst), Norway with reference number of 2015/2124 REK sør-øst B. Ethical approval was also obtained from the Institutional Review Board of Jimma University, Ethiopia with reference number of RPGC/389/2016. Permission was granted from Oromia regional health bureau, Ethiopia with reference number of BEFO/ABTF/1-8/2026 and Jimma zone health office, Ethiopia with reference number of WEFBJ/ 0-11/8060/08. Written (for literate) and oral (for illiterate) informed consent was secured from the study participants before starting the data collection. For minors (15 – 17years), assent was obtained from the study participants and consent was secured from their parents or guardians.

2.6. Inclusivity in global research

Additional information regarding the ethical, cultural and scientific considerations specific to inclusivity in global research is included in the S3 Text.

3. Results

3.1. Characteristics of the study participants

In this study, we assessed the length of total delay and associated factors among TB patients in Jimma Zone, Ethiopia. Accordingly, a total of 1,161 patients participated in this study: 774(66.7%) under FB-DOTS, 387(33.3%) under CB-DOTS) were included. Of these, 51.2% were male, 65.9% were married, and 39.5% were illiterate. The mean (± SD) age for the study participants was 32.2 (±14.41) years, with a range of 15 to 90 years. Nearly half (46.9%) of the patients were 25–44 years of age. Of the total study participants, 63.7% were farmers by occupation, 51.7% were rural residents, and 48.8% were smear-positive pulmonary TB patients (Table 1).

thumbnail
Table 1. Socio-demographic and clinical characteristics of the study participants in Jimma Zone, 2017 (N = 1,161).

https://doi.org/10.1371/journal.pone.0281546.t001

3.2. Study districts and time to reach the nearest medical provider

A majority (18.9%) of the study participants were from goma district. The mean (± SD) time taken to reach the nearest medical provider was 32.86 (±28.52) minutes, ranging from two to 180 minutes (Table 2).

thumbnail
Table 2. Districts and time to reach the nearest medical provider of the study participants at Jimma Zone, 2017 (N = 1,161).

https://doi.org/10.1371/journal.pone.0281546.t002

3.3. Patients’ first visit to medical providers

A total of 708 (60.98%) patients visited other medical providers (health posts and private clinics) before visiting the current health facility where they got their TB diagnosis and initiated anti-TB treatment. Of these, a majority (169) of the patients who first visited private clinic were not delayed. On the contrary, most (45) of the patients who visited health posts were delayed (Fig 2).

thumbnail
Fig 2. Medical provider first visited for the symptoms with patient delay status at Jimma Zone, 2017.

https://doi.org/10.1371/journal.pone.0281546.g002

3.4. Patient delay and total delay

The median patient delay (time from onset of symptoms until first visit to a medical provider) was 30 days [interquartile rang (IQR): 17.5, 60 days]. Whereas, the median total delay was 35 days (IQR: 25, 67 days). The total delay ranged from 4 to 732 days (Table 3).

thumbnail
Table 3. Patient, health system and total delays for the study participants in Jimma Zone, 2017.

https://doi.org/10.1371/journal.pone.0281546.t003

3.5. Determinants of total delay

The median total delay was 35(IQR 25, 67 days) days, and for more than half (586) of the patients, the total delay was > 35 days. Variables such as occupation, source of household income, being a smoker, alcohol use, khat chewing, HIV status, TB classification, chest pain, and weight loss were removed from the final model even if these were statistically significant during the bivariate analysis. In the multivariate analysis, patients who had poor knowledge about TB were about four times more likely to be delayed than patients who had good knowledge about TB (AOR = 3.92, 95% CI: 2.65, 5.80). Those patients who had swelling or wound in the neck region were three times more likely to be delayed than their counterpart (AOR = 3.02, 95% CI: 1.62, 5.62). Patients who attended college or university were 72% less likely to be delayed than those patients who did not read and write (AOR = 0.28, 95% CI: 0.10, 0.81). Female patients were about 1.5 times more likely to be delayed than their counterparts (AOR = 1.46, 95% CI: 1.00, 2.14). Patients who had a monthly household income of 1001–2500 ETB had increased total delay compared to patients who earned > 3500 ETB (AOR = 15.75, 95% CI: 2.92, 84.91). Those patients who traveled 30 or less minutes to reach the nearest medical provider were 53% less likely to be delayed than those patients who traveled more than 60 minutes (AOR = 0.47, 95% CI: 0.23, 0.94). Patients under CB-DOTS were about 1.5 times more likely to be delayed than their counterparts (AOR = 1.53, 95% CI: 1.02, 2.29). Patients who had no limitation of their day-to-day activity were less likely to be delayed than those patients who had high limitation of their day-to-day activity (AOR = 0.09, 95% CI: 0.01, 0.89) (Table 4).

thumbnail
Table 4. Determinents of total delay among the study partcipants at Jimma Zone, 2017.

https://doi.org/10.1371/journal.pone.0281546.t004

4. Discussion

In this study, we assessed the length and associated factors of total delay among TB patients. A systematic review and meta-analysis conducted in low- and middle-income countries reported that the median total delay ranged from 30 to 366.5 days [7]. We observed a median total delay of 35 days which is similar to the study done in Addis Ababa, Ethiopia [35], but lower than the findings reported from earlier studies conducted in different Regions of Ethiopia [23, 25, 3638]. The shorter total delay observed in the present study may be related to several reasons: these may include improved access to TB diagnostic and treatment facilities through decentralization of health services to the community, and health extension workers’ contribution in identifying suspected TB cases and referring them to health centers for smear microscopy test [39].

Even though the observed total delay in our study was relatively lower compared to earlier study findings in Ethiopia, it is still long delay given the need for immediate diagnosis and treatment initiation for TB patients. In a recent qualitative study conducted in the study area, different barriers were identified that may have implications for increased total delay. Among these were shortage of resources including basic infrastructure and limited TB diagnostic services; and delays in the diagnostic process at the health facilities [40]. Solving these barriers through targeted interventions is crucial to reduce the observed relatively long total delay. Long delays in diagnosis and treatment initiation increase the severity and complications of disease that may result in unfavorable treatment outcome [37, 41]. It also increases the risk of developing drug resistant TB which leads to treatment failure, high mortality rates, and high transmission rate of drug resistant TB [42, 43]. These findings emphasize the importance of early diagnosis and prompt treatment of TB. Conversely, the observed median total delay in the current study is higher than the study findings in other parts of Ethiopia that reported 23 days and 33 days [8, 9]. This discrepancy might be because of differences in the study settings i.e. socio-economic status, study population, access to TB diagnostic facilities, and utilization of health care services among the population.

The analysis of socio-demographic, economic, and clinical factors revealed significant associations with increased total delay. In line with our study, low level of education [7, 25, 36, 38], long distance [19, 36], and poor knowledge about TB [23, 36, 37] were identified as predictors of total delay in former studies in Ethiopia and elsewhere. Our findings underscored that educational level is an important determinant of total delay. A former study in Ethiopia revealed that individuals with a higher level of education had better knowledge about TB compared to those who did not read and write [44]. Our study showed that the educational level of the patients may not be directly associated with the delay but do significantly affect the knowledge level of the study participants. A study from the Gambia showed an association of educational level with knowledge, attitude and health-seeking behavior regarding TB [45]. Another study from Malaysia reported that TB education program at school was an effective intervention for improvement in the mean score of knowledge, preventive practice, and perceived stigma about TB [46]. In addition, a study conducted in Ethiopia indicated that there was association between educational level and knowledge about TB in which having good knowledge of TB led to a more positive attitude and better practice in relation to TB prevention and control [47]. This was supported by findings from a qualitative meta-synthesis conducted in Nigeria which reported that low education level and poor knowledge about TB were major barriers to TB diagnosis and treatment [20]. Compared to the uneducated persons, individuals with better educational level are more likely to have access to better economic situation which consecutively improves their access to health information and care [8, 44]. Moreover, the level of their knowledge about TB influence their perceptions about TB and change their health care-seeking behaviour [8, 44].

We observed a strong association between having swelling or wound in the neck region and long total delay. Cervical TB lymphadenitis is one of the most common manifestations of extra-pulmonary TB which contributes to diagnostic delay. The common sign and symptom is a chronic, painless swelling in the neck region (no other remarkable symptom). Thus, the diagnosis of this type of TB requires a high index of suspicion and use of different diagnostic methods. Practically, it is not possible to apply all diagnostic procedures for all symptomatic patients. In this regard, ruling out for other causes of neck mass could contribute to diagnostic delay. Because of the absence of culture and pathology services in most health centers in Ethiopia including the study area, it is difficult to early diagnose such type of TB [48, 49]. A study from Zanzibar showed that from all patients with long total delay (> 6 months), a majority (90%) were patients with TB lymphadenitis [50]. Extra-pulmonary TB cases are seldom infectious as they are considered to have less contribution in TB transmission. However, delay in starting treatment for the patients may result in disseminated TB and increased mortality [49, 50]. As peripheral health care facilities in the study area do not have the capacity to diagnose extra-pulmonary TB cases, it is important to develop diagnostic algorithms for timely referral of presumptive extra-pulmonary TB patients. Therefore, training is essential for the health extension workers so that they can screen TB lymphadenitis suspects in the community for prompt referral to the next level of health care for better diagnosis and treatment [51].

Our study revealed that women were more likely to have long total delay compared to men. This finding is consistent with former studies conducted in Ethiopia and elsewhere [36, 52, 53]. Economic status, cultural beliefs, and perceived stigma are barriers of early care seeking for most female patients [54]. In terms of cultural beliefs, women in Ethiopia give priority for their family than themselves, have main responsibility for children care, have less decision making power, and worries about preserving modesty might affect their health care seeking behavior [55]. Previous study revealed that women were more likely to suffer from TB stigma compared to men [56]. Women in high burden countries like Ethiopia experienced long delays in TB diagnosis and treatment because of challenges related to TB services [57]. Most women faced problems in accessing TB service because of resource limitations, power imbalances, and poor knowledge about TB [57]. Women who have less access to quality healthcare, and delayed to seek formal health care were prone to long delays [54]. This may partly be related to the fact that women have the main responsibility for domestic tasks and care for their family members, especially children and elders. Women often lack economic independence, have less time and are less empowered compared to men in regards to care for themselves [36]. Therefore, it is important to recognize sex differences in individual’s TB care-seeking. Targeted interventions that enhance women empowerment are required to improve poor health outcomes among women. Socio-economic support interventions could change their health seeking behaviour, improve adherence and treatment outcome for TB patients who are women [58, 59]. In addition, gender-based health education and behavioural change communication (BCC) interventions focusing on early health seeking counselling are required to reduce the burden of TB among women. BCC strategies are efficient, effective, sustainable and acceptable because messages can tailored to gender- or age-based target groups [60, 61].

Monthly household income was another determinant variable that was significantly associated with total delay. This finding is in line with previous study results from Ethiopia [8, 62, 63] and Pakistan [18]. This could be due to the fact that individuals who did not have adequate monthly income could not be able to seek health care early because of several reasons such as unaffordable medical costs and transport expenses [8, 63]. Therefore, they are likely to be prone to delayed diagnosis and treatment start. In resource limited settings like Ethiopia where there are several traditional practices and low access to quality health service, patients commonly seek health care from informal medical providers, as a result the patients might get traditional treatment that could delay them from timely seeking medical care from formal medical providers. TB diagnosis and treatment services in Ethiopia is given for free, money is mostly needed for covering costs for transportation, accommodation and food for the patient. Individuals who have low level of income may need to work long hours, as a result they may not have time to early seek health care when they get ill. Patients with inadequate income are more likely to visit formal-health care provider only when they become critically ill [8, 63]. A systematic review conducted in high TB burden settings reported that livelihood, work, and family were given priority which led them to have a long delay in health care-seeking [57]. This finding shows the importance of improving the socio-economic condition of the population for effective TB control. As per the Sustainable Development Goals (SDG), the world is committed to end poverty by 2030 [64, 65]. According to a recent World Bank report, the poverty rate in Ethiopia fell from 44 percent in 2000 to 21 percent in 2018 [66, 67]. If this trend continues, the contribution of poverty to TB disease and transmission may be significantly reduced in Ethiopia including the study area.

Time taken to reach the nearest medical provider was associated with total delay. Long distance traveling to reach the nearest health facility was also reported in previous studies conducted in Ethiopia and other countries as barrier to individuals’ health-seeking behavior which leads to lengthening of patient’s delay [17, 6872]. A recent qualitative study from the study area identified that long distance traveling to get TB diagnostic services was a barrier for most TB patients from the rural settings [40]. This could also be related with patients who were under FB-DOTS travel longer distance and more delayed than those patients under FB-DOTS.

Our study showed that patients under CB-DOTS were more likely to be delayed than those patients under FB-DOTS. This could be due to the fact that patients under CB-DOTS were rural residents and most of patients under FB-DOTS were urban residents. Rural residence was reported as independent predictor of delay in a systematic review conducted in Ethiopia [11]. One of the reasons might be that rural residents had poor access to health information and TB diagnostic and treatment facilities compared to urban residents. This might be due to the scarcity of formal health care providers in rural area of Ethiopia. Thus, patients from rural areas might take long chains of care-seeking through informal health care providers [57, 73]. A previous study from Southwest Ethiopia revealed that proportion of households sought care from formal health care providers was lower among rural compared to urban households [74]. Moreover, rural residents lack regular health information about the disease and do not seek health care early compared to the urban residents [10, 11]. In addition, rural residency makes it hard to travel to diagnostic and treatment facilities due to absence of road or distance (as long distance travelling discourages initiation of tuberculosis treatment) [10, 11].

This study has strengths and limitations. The strength of the study is that we included a relatively larger sample size compared to sample sizes used in other similar studies in Ethiopia. Thus, it provides more than adequate representative population to address the research questions. With regards to potential limitations, the study was only carried out in government health facilities; hence the findings cannot be generalized to all TB patients in the study area. There are also several private health care facilities and non-formal health care providers whereby TB patients may seek health care for their symptoms. Moreover, the present study focused on adult TB patients aged > 15 years who were treated at public health facilities; therefore, the results among other age groups and in other similar settings during the study period might be different. In addition, the reported duration of symptoms and first visit for treatment seeking is based on patients’ ability to recall and interpretation of their symptoms. Since patients might not exactly remember the exact date of start of their symptoms and first visit to a medical provider, it is subject to a recall bias. However, we have tried to reduce the recall bias by using different techniques such as using local calendars linking to major religious and national days to explain their perceived date of onset of TB symptoms and first visit to a medical provider.

5. Conclusion

The present study showed long total delay (the median total delay of 35 days) in diagnosis and treatment start for TB patients in the study area. The study also revealed important factors associated with total delay. Poor knowledge of TB, swelling or wound around the neck region, being women and low level of education were identified as factors associated with total delay. Several interventions are required to reduce the observed length of total delay. Efficient implementation strategies for early case detection and treatment initiation should be practiced to shorten total delay. Among others, well-crafted IEC and BCC strategies on TB need to be designed to increase awareness and health service utilization among the population in the study area. Swelling or wound around the neck region in a TB patient may be linked to TB lymphadenitis or disseminated TB. The health care facilities at peripheral level in the study area do not have the capacity to diagnose TB lymphadenitis cases. Thus, it is important to develop diagnostic algorithms for timely detection and referral of presumptive TB lymphadenitis patients to the nearest medical providers with the capacity to diagnose TB lymphadenitis. Then, the delay period among this group of patients is shortened and prompt treatment is initiated on time.

Supporting information

S1 Text. Questionnaire and information sheet with consent form English and local language versions.

https://doi.org/10.1371/journal.pone.0281546.s001

(PDF)

S3 Text. PLOS’ questionnaire on inclusivity in global research.

https://doi.org/10.1371/journal.pone.0281546.s003

(PDF)

S1 Data. Data for current study with SPSS.

https://doi.org/10.1371/journal.pone.0281546.s004

(SAV)

Acknowledgments

Our gratitude goes to the University of Oslo, Institute of Health and Society and Jimma University for supporting us to undertake this study. We would like to thank the Oromia Health Bureau, the Jimma Zone and Jimma Town health offices and all the study participants for providing us with the necessary information.

References

  1. 1. World Health Organization. Global Tuberculosis Report. France; 2019.
  2. 2. World Health Organization. Global tuberculosis report 2020. Geneva; 2020.
  3. 3. World Health Organization. Global Tuberculosis Report 2021. Geneva: World; 2021.
  4. 4. Ministry of Health Ethiopia. ANNUAL PERFORMANCE REPORT 2020/2021. Addis Ababa, Ethiopia; 2020.
  5. 5. Federal Democratic republic of Ethiopia Ministry of Health. National Guidelines for TB, DR-TB and Leprosy in Ethiopia. Sixth Edit. Addis Ababa, Ethiopia; 2018.
  6. 6. Ministry of Health Ethiopia. HEALTH & HEALTH RELATED INDICATORS 2020/2021. Addis Ababa, Ethiopia; 2020.
  7. 7. Getnet F, Demissie M, Assefa N, Mengistie B, Worku A. Delay in diagnosis of pulmonary tuberculosis in low-and middle-income settings: Systematic review and meta-analysis. BMC Pulmonary Medicine. 2017;17. pmid:29237451
  8. 8. Ayalew YE, Fikadu Ambaw Yehualashet WAB, Gobeza MB. Delay for Tuberculosis Treatment and Its Predictors among Adult Tuberculosis Patients at Debremarkos Town Public Health. Tuberclosis Research and Treatment. 2020;2020. pmid:33014464
  9. 9. Datiko DG, Jerene D, Suarez P. Patient and health system delay among TB patients in Ethiopia: Nationwide mixed method cross-sectional study. BMC Public Health. 2020;20. pmid:32680489
  10. 10. Abdu M, Balchut A, Girma E, Mebratu W. Patient Delay in Initiating Tuberculosis Treatment and Associated Factors in Oromia Special Zone, Amhara Region. Pulmonary Medicine. 2020;2020. pmid:32577313
  11. 11. Obsa SM, Binu WD, Wosene NG, Gebremedhin D, Chemeda D, Edosa , et al. Treatment seeking delay and associated factors among tuberculosis patients attending health facility in Ethiopia from 2000 to 2020: A systematic review and meta analysis. PLoS ONE. 2021;16: e0253746. pmid:34197515
  12. 12. World Health Organization. The End TB Strategy: Global strategy and targets for tuberculosis prevention, care and control after 2015. 2015.
  13. 13. World Health Organization (WHO). Global Tuberculosis Report. France; 2018.
  14. 14. Peri AM, Bernasconi DP, Galizzi N, Matteelli A, Codecasa L, Giorgio V, et al. Determinants of patient and health care services delays for tuberculosis diagnosis in Italy: a cross-sectional observational study. BMC infectious diseases. 2018;18. pmid:30572830
  15. 15. Nogueira B, Rolla C, Akrami KM, Kiene SM. Factors associated with tuberculosis treatment delay in patients co-infected with HIV in a high prevalence area in Brazil. PLoS ONE. 2018;13: 1–14. Available: https://doi.org/10.1371/ journal.pone.0195409%0A
  16. 16. Owolabi OA, Jallow AO, Jallow M, Sowe G. Delay in the diagnosis of pulmonary tuberculosis in The Gambia, West Africa: A cross-sectional study. International Journal of Infectious Diseases. 2020;101: 102–106. Available: http://creativecommons.org/licenses/by-nc- nd/4.0 pmid:32949776
  17. 17. Said K, Hella J, Mhalu G, Chiryankubi M, Masika E, Maroa T, et al. Diagnostic delay and associated factors among patients with pulmonary tuberculosis in Dar es Salaam, Tanzania. Infectious Diseases of Poverty. 2017;6. pmid:28335816
  18. 18. Saqib SE, Ahmad MM, Amezcua-prieto C. Treatment Delay among Pulmonary Tuberculosis Patients within the Pakistan National Tuberculosis Control Program. AmJTropMedHyg. 2018;99: 143–149. pmid:29761768
  19. 19. Nguyen HT, Duong B, Beach L. Delays in the diagnosis and treatment of tuberculosis patients in Vietnam: A cross-sectional study. BMC Public Health. 2007;7. pmid:17567521
  20. 20. Oga-omenka C, Wakdet L, Menzies D, Zarowsky C. A qualitative meta-synthesis of facilitators and barriers to tuberculosis diagnosis and treatment in Nigeria. BMC Public Health. 2021;21. pmid:33535990
  21. 21. Takarinda KC, Harries AD, Nyathi B, Ngwenya M, Mutasa-apollo T, Sandy C. Tuberculosis treatment delays and associated factors within the Zimbabwe national tuberculosis programme. BMC Public Health. 2015;15: 1–12. pmid:25631667
  22. 22. Fetensa G, Wirtu D, Etana B, Tolossa T, Wakuma B. Magnitude and determinants of delay in diagnosis of tuberculosis patients in Ethiopia: a systematic review and meta-analysis: 2020. Archives of Public Health. 2022;80. pmid:35287725
  23. 23. Hamza A, Demissie M, Gare S, Teshome G. Delay in Tuberculosis Diagnosis among Tuberculosis Patients at the Three Hospitals: Asella, Robe and Abomsa of Arsi Zone, Oromia Regional State, March, 2015. Open Access Library Journal. 2015;2: 1–13.
  24. 24. Evenden P, Roche A, Karo B, Balasegaram S, Anderson CS. Presentation and healthcare delays among people with tuberculosis in London, and the impact on treatment outcome. BMJ Open Respiratory Resaerch. 2019;6: 1–11. pmid:31673368
  25. 25. Asefa A, Teshome W. Total Delay in Treatment among Smear Positive Pulmonary Tuberculosis Patients in Five Primary Health Centers, Southern Ethiopia: A Cross Sectional Study. PLoS ONE. 2014;9. pmid:25048601
  26. 26. Seid A, Metaferia Y. Factors associated with treatment delay among newly diagnosed tuberculosis patients in Dessie City and surroundings, Northern Central Ethiopia: A cross-sectional study. BMC Public Health. 2018;18: 1–13. pmid:30055593
  27. 27. Central Statistical Authority. 2007 POPULATION and HOUSING CENSUS OF Ethiopia. Addis Ababa, Ethiopia; 2012.
  28. 28. Ereso BM, Sagbakken M, Gradmann C, Yimer SA. Treatment outcomes of patients with drug-sensitive tuberculosis under community- based versus facility-based directly observed treatment, short course strategy in Southwest Ethiopia: a prospective cohort study. BMJ Open. 2021;11. pmid:34290068
  29. 29. Boogaard J Van Den, Lyimo R, Irongo CF, Boeree MJ, Schaalma H, Aarnoutse RE, et al. Community vs. facility-based directly observed treatment for tuberculosis in Tanzania ‘ s Kilimanjaro Region. Int J Tuber Lung Dis,. 2009;13: 1524–1529. pmid:19919771
  30. 30. Datiko DG, Lindtjørn B. Health Extension Workers Improve Tuberculosis Case Detection and Treatment Success in Southern Ethiopia: A Community Randomized Trial. 2009;4: e5443.
  31. 31. Federal MoH Ethiopia. Guidelines for clinical and programmatic management of TB, leprosy and TB/HIV in Ethiopia. 6th Editio. Addis Ababa, Ethiopia; 2016.
  32. 32. World Health Organization (WHO). Treatment of tuberculosis, Guidlines for treatment of drug susceptible tuberculosis and patient care [Internet]. Geneva, Switzerland; 2017. Available: http://apps.who.int/iris.
  33. 33. Yassin MA, Datiko DG, Tulloch O, Markos P, Aschalew M, Shargie EB, et al. Innovative Community-Based Approaches Doubled Tuberculosis Case Notification and Improve Treatment Outcome in Southern Ethiopia. PLoS ONE. 2013;8: e63174. pmid:23723975
  34. 34. Datiko DG, Lindtjørn B. Cost and Cost-Effectiveness of Treating Smear-Positive Tuberculosis by Health Extension Workers in Ethiopia: An Ancillary Cost-Effectiveness Analysis of Community Randomized Trial. PLoS ONE. 2010;5: e9158. pmid:20174642
  35. 35. Adenager GS, Alemseged F, Asefa H, Gebremedhin AT. Factors Associated with Treatment Delay among Pulmonary Tuberculosis Patients in Public and Private Health Facilities in Addis Ababa, Ethiopia. Tuberclosis Research and Treatment. 2017;2017. pmid:28348887
  36. 36. Awoke N, Dulo B, Wudneh F. Total Delay in Treatment of Tuberculosis and Associated Factors among New Pulmonary TB Patients in Selected Health Facilities of Gedeo Zone, Southern Ethiopia, 2017 / 18. interdisciplanry persepctive on infectious disease. 2019;2019. pmid:31275370
  37. 37. Gebreegziabher SB, Bjune GA, Yimer SA. Total Delay Is Associated with Unfavorable Treatment Outcome among Pulmonary Tuberculosis Patients in West Gojjam Zone, Northwest Ethiopia: A Prospective Cohort Study. PLoS ONE. 2016;11. pmid:27442529
  38. 38. Hussen A, Biadgilign S, Tessema F, Mohammed S, Deribe K, Deribew A. Treatment delay among pulmonary tuberculosis patients in pastoralist communities in Bale Zone, Southeast Ethiopia. BMC Resaerch Note. 2012;5. Available: http://www.biomedcentral.com/1756-0500/5/320 pmid:22720757
  39. 39. Datiko DG, Yassin MA, Theobald SJ, Blok L, Suvanand S, Creswell J, et al. Health extension workers improve tuberculosis case finding and treatment outcome in Ethiopia: A large-scale implementation study. BMJ Global Health. 2017;2: 1–8. pmid:29209537
  40. 40. Ereso BM, Yimer SA, Gradmann C, Sagbakken M. Barriers for tuberculosis case finding in Southwest Ethiopia: A qualitative study. PLoS ONE. 2020;15: 1–20. pmid:31895932
  41. 41. Virenfeldt J, Rudolf F, Camara C, Furtado A, Gomes V, Aaby P, et al. Treatment delay affects clinical severity of tuberculosis: a longitudinal cohort study. BMJ Open. 2014;4. pmid:24916087
  42. 42. Kuznetsov VN, Grjibovski AM, Mariandyshev AO, Johansson E, Bjune GA. Two vicious circles contributing to a dignostic delay for tuberculosis patients in Arkhangelsk. Emerging Health Threats J. 2014;7. pmid:25163673
  43. 43. Mahato RK, Laohasiriwong W, Vaeteewootacharn K. Major Delays in the Diagnosis and Management of Tuberculosis Patients in Nepal. Journal of clinical and dignostic resaerch. 2015;9: 5–9. pmid:26557545
  44. 44. Daniel G Datiko, Habte D, Jerene D, Suarez P. Knowledge, attitudes, and practices related to TB among the general population of Ethiopia: Findings from a national cross-sectional survey. PLoS ONE. 2019;14: e0224196. pmid:31658300
  45. 45. Bashorun AO, Linda C, Omoleke S, Kendall L, Donkor SD, Kinteh M, et al. Knowledge, attitude and practice towards tuberculosis in Gambia: a nation-wide cross-sectional survey. BMC Public Health. 2020;20. pmid:33069220
  46. 46. Idris NA, Rosnani Z, Rosediani M, Rosmawati NH, Azlina I, Zahiruddin WM. The Effectiveness of Tuberculosis Education Programme in Kelantan, Malaysia on Knowledge, Attitude, Practice and Stigma Towards Tuberculosis among Adolescents. Malays J Med Sci. 2020;27: 102–114. pmid:33447138
  47. 47. Adane K, Spigt M, Johanna L, Noortje D, Abera SF, Dinant GJ. Tuberculosis knowledge, attitudes, and practices among northern Ethiopian prisoners: Implications for TB control efforts. PLoS ONE. 2017;12. pmid:28358877
  48. 48. Deveci HS, Kule M, Kule ZA, Habesoglu TE. Diagnostic challenges in cervical tuberculous lymphadenitis: A review. North Clin Istanbul. 2016;3: 150–155. pmid:28058405
  49. 49. Tagne Nouemssi AB. Disseminated tuberculous lymphadenitis presenting as cervical mass in patient with HIV infection, worsening after antiretroviral initiation: diagnosis and treatment challenges. BMJ Case Rep. NY, United states of America; 2018. pmid:29545423
  50. 50. Jørstad MD, Aẞmus J rg, Marijan M, Sviland L, Mustafa T. Diagnostic delay in extrapulmonary tuberculosis and impact on patient morbidity: A study from Zanzibar. PLoS ONE. 2018;13: e0203593. pmid:30188947
  51. 51. Biadglegne F, Tesfaye W, Sack U, Rodloff AC. Tuberculous Lymphadenitis in Northern Ethiopia: In a Public Health and Microbiological Perspectives. PLoS ONE. 2013;8: e81918. pmid:24349151
  52. 52. Krishnan L, Akande T, Shankar A V, Mcintire KN, Gounder CR, Gupta A, et al. Gender-Related Barriers and Delays in Accessing Tuberculosis Diagnostic and Treatment Services: A Systematic Review of Qualitative Studies. Tuberclosis Research and Treatment. 2014;2014. pmid:24900921
  53. 53. Lee C, Wang J, Lin H, Lin P, Chang J, Suk C, et al. Treatment delay and fatal outcomes of pulmonary tuberculosis in advanced age: a retrospective nationwide cohort study. BMC Infectious Diseases. 2017;17. pmid:28646854
  54. 54. Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M. The Social Determinants of Tuberculosis: From Evidence to Action. American Journal of Public Health. 2011;101: 654–662. pmid:21330583
  55. 55. Gamtesa DF, Tola HH, Mehamed Z, Tesfaye E, Alemu A. Health care seeking behavior among presumptive tuberculosis patients in Ethiopia: a systematic review and meta- analysis. BMC health services research. 2020;20. pmid:32429988
  56. 56. Chang S, Cataldo JK. A systematic review of global cultural variations in knowledge, attitudes and health responses. Int J Tuberc Lung Dis. 2014;18: 168–173. https://doi.org/10.5588/ijtld.13.0181 A
  57. 57. Teo KAJ, Singh SR, Prem K, Hsu LY, Yi S. Duration and determinants of delayed tuberculosis diagnosis and treatment in high - burden countries: a mixed - methods systematic review and meta - analysis. Respiratory Research. 2021;22. pmid:34556113
  58. 58. Hoorn R Van, Jaramillo E, Collins D, Gebhard A, Hof S Van Den. The Effects of Psycho-Emotional and Socio- Economic Support for Tuberculosis Patients on Treatment Adherence and Treatment Outcomes–A Systematic Review and Meta- Analysis. PLoS ONE. 2016;11: e0154095. pmid:27123848
  59. 59. Peddireddy V. Quality of Life, Psychological Interventions and Treatment Outcome in Tuberculosis Patients: The Indian Scenario Psychological Distress in Tuberculosis. Frontiers in Psychology. 2016;7. pmid:27833578
  60. 60. López-alcalde J, Stallings E, Nunes SC, Chávez AF, Daheron M, Cosp XB, et al. Consideration of sex and gender in Cochrane reviews of interventions for preventing healthcare-associated infections: a methodology study. BMC Health Services Research. 2019;19. pmid:30876452
  61. 61. Ngigi S, Busolo DN. Behaviour Change Communication in Health Promotion: Appropriate Behaviour Change Communication in Health Promotion: Appropriate Practices and Promising Approaches. International Journal of Innovative Research and Development ·. 2018;7.
  62. 62. Wondawek TM, Ali MM. Delay in treatment seeking and associated factors among suspected pulmonary tuberculosis patients in public health facilities of Adama town, eastern Ethiopia. BMC Public Health. 2019;19. pmid:31727034
  63. 63. Bogale S, Diro E, Shiferaw AM, Yenit MK. Factors associated with the length of delay with tuberculosis diagnosis and treatment among adult tuberculosis patients attending at public health facilities in. BMC infectious diseases. 2017;17: 1–10. pmid:28193183
  64. 64. Tulder R Van, Rodrigues SB. The UN ‘ s Sustainable Development Goals: Can multinational enterprises lead the Decade of Action? Journal of International Business Policy. 2021;2021.
  65. 65. GBD 2017 SDG Collaborators. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392: 2091–2138. pmid:30496107
  66. 66. World Bank. Poverty Overview: Development news resaerch data [Internet]. 2021 [cited 26 Dec 2021]. Available: https://www.worldbank.org/en/topic/poverty/overview#1
  67. 67. Thelwell K. SUCCESSFUL DEVELOPMENT: REDUCING POVERTY IN ETHIOPIA [Internet]. 2019 [cited 26 Dec 2021]. Available: https://borgenproject.org/tag/poverty-in-ethiopia/
  68. 68. Huong NT, Vree M, Duong BD, Khanh VT, Loan VT, Co N V., et al. Delays in the diagnosis and treatment of tuberculosis patients in Vietnam: A cross-sectional study. BMC Public Health. 2007;7: 1–8. pmid:17567521
  69. 69. Fluegge K, Malone LL, Nsereko M, Okware B, Wejse C, Kisingo H, et al. Impact of geographic distance on appraisal delay for active TB treatment seeking in Uganda: A network analysis of the Kawempe Community Health Cohort Study. BMC Public Health. 2018;18. pmid:29940918
  70. 70. Ukwaja KN, Alobu I, Nweke CO, Onyenwe EC. Healthcare-seeking behavior, treatment delays and its determinants among pulmonary tuberculosis patients in rural Nigeria: A cross-sectional study. BMC health services research. 2013;13: 1–9. pmid:23327613
  71. 71. Mesfin MM, Newell JN, Walley JD, Gessessew A, Madeley RJ. Delayed consultation among pulmonary tuberculosis patients: A cross sectional study of 10 DOTS districts of Ethiopia. BMC Public Health. 2009;9: 1–10. pmid:19203378
  72. 72. Getnet F, Hashi A, Mohamud S, Mowlid H, Klinkenberg E. Low contribution of health extension workers in identification of persons with presumptive pulmonary tuberculosis in Ethiopian Somali Region pastoralists. BMC Health Services Research. 2017;17: 1–9. pmid:28284193
  73. 73. Alene M, Assemie MA, Yismaw L, Gedif G, Ketema DB. Patient delay in the diagnosis of tuberculosis in Ethiopia: a systematic review and meta-analysis. BMC Infectious Diseases. 2020;20. pmid:33109110
  74. 74. Begashaw B, Tessema F, Gesesew HA. Health Care Seeking Behavior in Southwest Ethiopia. PLoS ONE. 2016;11: e0161014. pmid:27626804